Dolby Laboratories (NYSE:DLB) Updates FY 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 3.990-4.140 for the period, compared to the consensus earnings per share estimate of 3.700. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Dolby Laboratories also updated its FY25 guidance to $2.43-2.58 EPS.

Dolby Laboratories Trading Down 0.6 %

Shares of DLB traded down $0.42 during midday trading on Tuesday, hitting $70.93. The stock had a trading volume of 416,799 shares, compared to its average volume of 396,175. The firm has a market cap of $6.76 billion, a P/E ratio of 32.38 and a beta of 0.98. Dolby Laboratories has a fifty-two week low of $66.35 and a fifty-two week high of $90.06. The business has a 50-day simple moving average of $73.66 and a two-hundred day simple moving average of $76.09.

Dolby Laboratories announced that its board has initiated a share repurchase program on Wednesday, August 7th that authorizes the company to repurchase $350.00 million in shares. This repurchase authorization authorizes the electronics maker to repurchase up to 5% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on DLB shares. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price target on shares of Dolby Laboratories in a research note on Friday, September 20th. StockNews.com raised shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Monday.

Insider Transactions at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 28,512 shares of the stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total value of $2,113,309.44. Following the completion of the sale, the chief executive officer now owns 83,721 shares in the company, valued at approximately $6,205,400.52. This trade represents a 25.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 39.54% of the stock is currently owned by corporate insiders.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.